Jennifer Doudna, one of the inventors of the breakthrough gene-editing tool CRISPR, says the technology will help the world ...
Jennifer Doudna, one of the inventors of the breakthrough gene-editing tool CRISPR, says the technology will help the world grapple with the growing risks of climate change by delivering crops and ...
Nobel Prize winner and UC Berkeley professor Jennifer Doudna presented developments on her gene research at a UC Santa Barbara Arts & Lectures event on Oct. 22.
The US, which is currently the world’s second-largest greenhouse-gas emitter and has added more climate pollution to the atmosphere than any other nation, is now very unlikely to hit Biden’s 2030 goal ...
Canaccord Genuity analyst Whitney Ijem has maintained their bullish stance on NTLA stock, giving a Buy rating today. Whitney Ijem has given ...
JMP Securities analyst Silvan Tuerkcan has maintained their neutral stance on NTLA stock, giving a Hold rating on October 25. Silvan ...
The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered ...
The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered ...
In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report), ...
The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered ...
The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback